Exploratory analysis of molecular pharmacodynamic effects of vilaprisan in the endometrium

Andrea Wagenfeld; A. Schulz; Marcus‐Hillert Schultze‐Mosgau; Barbara Schuett; K. Machens; Beate Rohde

doi:10.1016/j.fertnstert.2018.07.399

Exploratory analysis of molecular pharmacodynamic effects of vilaprisan in the endometrium

Andrea Wagenfeld, A. Schulz, Marcus‐Hillert Schultze‐Mosgau, Barbara Schuett, K. Machens, Beate Rohde

In: Fertility and Sterility · 2018 · vol. 110(4) , pp. e134–e135 · doi:10.1016/j.fertnstert.2018.07.399 · W2892227643

article OA: closed CC0 ⤵ 1 in-corpus citation

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study explored the molecular pharmacodynamic effects of viliprisan treatment on the endometrium, analyzing changes in gene expression and cellular pathways.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Endometriosis is a risk factor for incorrectly diagnosed laterality of ectopic pregnancy on pelvic ultrasound 2018

Cited by (1)

Endometriosis is a risk factor for incorrectly diagnosed laterality of ectopic pregnancy on pelvic ultrasound 2018

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall: last seen: 2026-08-12T06:43:03.944938+00:00

License: CC0 · commercial use OK